Gujarat Kidney Shares Plunge 9% on Debut Day After Premium Listing

• Gujarat Kidney shares settled 9.25% lower at Rs 103.46 on NSE on their debut day.
• The shares initially listed at a premium of over 5% (Rs 120 on NSE, Rs 120.75 on BSE) compared to the IPO price band of Rs 108-114.
• The Rs 251-crore IPO was subscribed 5.21 times between December 22-24.
• Expert Ravi Singh of Master Capital Services Ltd sees long-term potential for Gujarat Kidney due to healthcare sector growth and company strategy.
• IPO proceeds will fund the acquisition of Parekhs Hospital in Ahmedabad and part-payment for Ashwini Medical Centre.

Why It Matters: Gujarat Kidney shares saw a volatile debut, closing lower despite an initial premium listing, with experts suggesting long-term potential.